Alan Keller
Impact in
- Oncology top 1%
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Cancer Diagnosis and Treatment
- Peptidase Inhibition and Analysis
- Hematology top 1%
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 4
-
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Oscar BallesterAllan LiptonMichael J. KovacsAlan LichtensteinDirk J. ReitsmaJames R. BerensonRobert KnightMeletios Α. Dimopoulos
- Journals
- Journal of Clinical Oncology (6 papers)Cancer (3 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)New England Journal of Medicine (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Alan Keller
23 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.8k
- Hematology 698
- Orthopedics and Sports Medicine 323
- Pulmonary and Respiratory Medicine 665
- Radiology, Nuclear Medicine and Imaging 403
Countries citing papers authored by Alan Keller
This map shows the geographic impact of Alan Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Keller more than expected).
Fields of papers citing papers by Alan Keller
This network shows the impact of papers produced by Alan Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Keller. The network helps show where Alan Keller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Keller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2018 | 12 | |
| 3 | 2016 | 3 | |
| 4 | 2009 | 60 | |
| 5 | 2004 | 7 | |
| 6 | 2004 | 168 | |
| 7 | 1998 | 20 | |
| 8 | 1998 | 486 | |
| 9 | Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma Hit paper breakdown → | 1996 | 780 |
| 10 | 1996 | 83 | |
| 11 | 1994 | 7 | |
| 12 | 1992 | 114 | |
| 13 | 1988 | 9 | |
| 14 | 1987 | 7 | |
| 15 | Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma. | 1987 | 6 |
| 16 | Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia. | 1987 | 7 |
| 17 | High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group. | 1985 | 15 |
| 18 | 1984 | 98 | |
| 19 | 1984 | 11 | |
| 20 | 1982 | 10 |
About Alan Keller
Alan Keller is a scholar working on Genetics, Hematology, Oncology, Cancer Research and Dermatology, having authored 23 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Bone health and treatments (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Multiple Myeloma Research and Treatments (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). The work is most often cited by research in Oncology (1.8k citations), Hematology (698 citations), Orthopedics and Sports Medicine (323 citations), Pulmonary and Respiratory Medicine (665 citations) and Radiology, Nuclear Medicine and Imaging (403 citations). Alan Keller has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Oscar Ballester, Allan Lipton, Michael J. Kovacs, Alan Lichtenstein, Dirk J. Reitsma, James R. Berenson, Robert Knight, Meletios Α. Dimopoulos, Joseph F. Simeone and John J. Seaman. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, New England Journal of Medicine and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.